![Claudio Ullmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Claudio Dansky Ullmann formerly worked at Takeda Pharmaceutical Co., Ltd., as Senior Medical Director from 2012 to 2015, MaxCyte, Inc., as Chief Medical Officer, Infinity Pharmaceuticals, Inc., as Senior Vice President-Clinical Development, Avenge Bio, Inc., as Chief Medical Officer, and Context Therapeutics, Inc., as Chief Medical Officer from 2024 to 2025.
Dr. Ullmann received his graduate degree from Universidad de Buenos Aires.
Eerdere bekende functies van Claudio Ullmann
| Bedrijven | Functie | Einde |
|---|---|---|
| CONTEXT THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 10-05-2025 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Hoofd Techniek/Wetenschap/O&O | 01-01-2015 |
Avenge Bio, Inc.
 Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company | Hoofd Techniek/Wetenschap/O&O | - |
| MAXCYTE, INC. | Hoofd Techniek/Wetenschap/O&O | - |
| INFINITY PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Claudio Ullmann
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
17
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
MaxCyte, Inc.
 MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Universidad de Buenos Aires
 Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avenge Bio, Inc.
Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company | Health Technology |
Context Therapeutics, Inc.
 Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
